Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury
Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury
复制标题
CRMP2磷酸化的基因抑制可延缓视神经损伤后的沃勒变性
DOI:
10.1016/j.bbrc.2019.05.060
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Ohshima T
中科院分区:
文献类型:
--
作者:
Kinoshita Y;Kondo S;Takahashi K;Nagai J;Wakatsuki S;Araki T;Goshima Y;Ohshima T
Axonal degeneration occurs in patients with various neurological diseases and traumatic nerve injuries, and Wallerian degeneration is a phenomenon in the prototypical axonal degradation that is observed after injury. Collapsin response mediator protein 2 (CRMP2) is phosphorylated by glycogen synthase kinase 3β (GSK3β), and it is involved in Wallerian degeneration after optic nerve injury. We previously developed aCRMP2knock-in (CRMP2KI) mouse line, in which CRMP2 phosphorylation by GSK3β is inhibited; however, Wallerian degeneration inCRMP2KI mice has not yet been examined.In this study, we examined whether Wallerian degeneration of the optic nerve is suppressed inCRMP2KI mice. Using one eye removal model, we compared Wallerian degeneration of the optic nerve based on histological and biochemical analyses. Our experimental results indicated that the genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.